<?xml version="1.0" encoding="UTF-8"?>
<ref id="R37">
 <label>37.</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Kantarjian</surname>
   <given-names>HM</given-names>
  </name>, 
  <name>
   <surname>Thomas</surname>
   <given-names>XG</given-names>
  </name>, 
  <name>
   <surname>Dmoszynska</surname>
   <given-names>A</given-names>
  </name>, 
  <etal/>
  <article-title>Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia</article-title>. 
  <source>J Clin Oncol</source>. 
  <year>2012</year>;
  <volume>30</volume>:
  <fpage>2670</fpage>â€“
  <lpage>2677</lpage>.
  <pub-id pub-id-type="pmid">22689805</pub-id>
 </mixed-citation>
</ref>
